TWENTY-FIVE YEARS of dogged, often tedious, research into the development of an effective vaccine against a major cause of severe, sometimes lethal diarrhea among children is about to pay off. The Food and Drug Administration (FDA) is expected soon to approve marketing of a vaccine against rotavirus, making it available to pediatricians in the United States. The World Health Organization (WHO) is considering recommending its use in developing countries, where the disease more often has a serious outcome.
Marwick C. Rotavirus Vaccine a Boon to Children. JAMA. 1998;279(7):489-490. doi:10.1001/jama.279.7.489